ID

19643

Descripción

Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00719173

Link

https://clinicaltrials.gov/show/NCT00719173

Palabras clave

Versiones (1)
  1. 18/1/17 18/1/17 -
Subido en

18 de enero de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00719173

Inglés

Eligibility Breast Cancer NCT00719173

1 formularios  
Criteria
Descripción

Criteria

diagnosis of breast cancer
Descripción

Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
planning to receive cyclophosphamide 600 mg/m²-1,000 mg/m² iv infusion
Descripción

Cyclophosphamide Intravenous infusion Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0021440
UMLS CUI [1,3]
C1301732
no cyclophosphamide dose change between courses 1 and 2
Descripción

Cyclophosphamide Dose unchanged

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010583
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0442739
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
life expectancy ≥ 2 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
anc ≥ 1,500/μl
Descripción

Absolute neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948762
platelet count ≥ 100 x 10^9/l
Descripción

Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
hemoglobin ≥ 9.0 g/dl
Descripción

Hemoglobin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
serum creatinine ≤ 1.5 mg/dl
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
ast/alt ≤ 2 times upper limit of normal
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
not pregnant or nursing
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
no contraindication to aprepitant
Descripción

Medical contraindication aprepitant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1176306
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Descripción

disease characteristic

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0599878
no concurrent medications that are cyp3a4 substrates, inhibitors, and/or inducers, with the exception of the dexamethasone contained as part of the standard antiemetic regimen
Descripción

Cytochrome P-450 CYP3A4 Substrate | Cytochrome P450 3A4 Inhibitor | Cytochrome P450 3A4 Inducer | Dexamethasone | Antiemetics Standard therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714798
UMLS CUI [1,2]
C3891814
UMLS CUI [2]
C3830624
UMLS CUI [3]
C3830625
UMLS CUI [4]
C0011777
UMLS CUI [5,1]
C0003297
UMLS CUI [5,2]
C2936643
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00719173

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Breast Carcinoma
Item
diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
Cyclophosphamide Intravenous infusion Planned
Item
planning to receive cyclophosphamide 600 mg/m²-1,000 mg/m² iv infusion
boolean
C0010583 (UMLS CUI [1,1])
C0021440 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Cyclophosphamide Dose unchanged
Item
no cyclophosphamide dose change between courses 1 and 2
boolean
C0010583 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0442739 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Life Expectancy
Item
life expectancy ≥ 2 months
boolean
C0023671 (UMLS CUI [1])
Absolute neutrophil count
Item
anc ≥ 1,500/μl
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count ≥ 100 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
hemoglobin ≥ 9.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine ≤ 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast/alt ≤ 2 times upper limit of normal
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Medical contraindication aprepitant
Item
no contraindication to aprepitant
boolean
C1301624 (UMLS CUI [1,1])
C1176306 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
disease characteristic
Item
see disease characteristics
boolean
C0599878 (UMLS CUI [1])
Cytochrome P-450 CYP3A4 Substrate | Cytochrome P450 3A4 Inhibitor | Cytochrome P450 3A4 Inducer | Dexamethasone | Antiemetics Standard therapy
Item
no concurrent medications that are cyp3a4 substrates, inhibitors, and/or inducers, with the exception of the dexamethasone contained as part of the standard antiemetic regimen
boolean
C3714798 (UMLS CUI [1,1])
C3891814 (UMLS CUI [1,2])
C3830624 (UMLS CUI [2])
C3830625 (UMLS CUI [3])
C0011777 (UMLS CUI [4])
C0003297 (UMLS CUI [5,1])
C2936643 (UMLS CUI [5,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial